Belgium’s largest drugmaker UCB on Friday announced the successful closing of the sale, divestment and license of its mature ...

AstraZeneca and Daiichi Sankyo’s breast cancer drug Enhertu to join China’s state health insurance in 2025, enhancing ...

Allink Biotherapeutics, a Chinese startup specializing in bispecific antibodies and antibody-drug conjugates, raises $42 ...

Minghui Pharmaceutical announces successful Phase III trial of MH004 for atopic dermatitis, achieving significant skin ...

The Danish Ministry of Interior and Health has announced that the political parties have decided to permanently legalize ...

Galderma announces successful Phase III trial results for Nemluvio in treating prurigo nodularis, driving record trading ...

China’s Innovent Biologics has announced that the updated 2024 National Reimbursement Drug List (NRDL) now includes Sintbilo ...

During the Belgian Economic Mission to Brazil, a historic Memorandum of Understanding (MoU) was signed between the Brazilian ...

Evotec's COO Craig Johnstone will leave by year-end as the company implements its Priority Reset restructuring amid declining ...

Indian drugmaker Dr Reddy’s Laboratories has launched its toripalimab in the domestic market, sending the firm’s share up 2%.

French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to ...

Roche’s Phase III SKYSCRAPER-01 trial missed its primary endpoint, with tiragolumab combined with Tecentriq failing to ...